Indian manufacturer hit with Form 483 — again
An India-based generics manufacturer is once again feeling the wrath of US regulators.
Aurobindo Pharma has been slapped with a Form 483 following an inspection …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.